aggressive behavior - Nursing Case Study

Pathophysiology

• Primary mechanism: Dysregulation of the serotonergic system, particularly in the prefrontal cortex and limbic system, reduces inhibitory control over impulsive and aggressive responses, leading to heightened aggression.

• Secondary mechanism: Hyperactivity of the dopaminergic pathways, especially in the mesolimbic system, enhances reward sensitivity and aggressive behavior reinforcement, contributing to repeated aggressive outbursts.

• Key complication: Chronic aggressive behavior can lead to severe social and occupational dysfunction, increased risk of injury to self and others, and co-morbid psychiatric conditions such as anxiety and depression, exacerbating the underlying neurochemical imbalances.

Patient Profile

Demographics:

45-year-old male, construction worker

History:

• Key past medical history: History of traumatic brain injury, bipolar disorder, and substance abuse (alcohol and methamphetamines)

• Current medications: Lithium, risperidone, and lorazepam as needed

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Aggressive outbursts and violent behavior

• Key symptoms: Severe agitation, inability to focus, and verbal threats

• Vital signs: Blood pressure 180/110 mmHg, heart rate 130 bpm, respiratory rate 28 breaths per minute, temperature 100.4°F, SpO2 92% on room air

Section 1

As the case unfolds, the initial assessment reveals several critical findings that demand urgent attention and nuanced clinical judgment. Upon physical examination, the patient exhibits signs of autonomic hyperactivity: profuse sweating, dilated pupils, and tremors are evident, suggesting a heightened adrenergic response. Neurologically, he is disoriented to time and place, with impaired short-term memory and poor insight into his current state. His speech is pressured and tangential, further complicating any attempt to de-escalate his heightened agitation. The nursing staff notes multiple contusions and abrasions on his forearms, likely from previous altercations or self-injurious behavior, underscoring the urgency of intervening to prevent further harm.

Laboratory investigations provide additional insights into the patient's condition. A comprehensive metabolic panel reveals hyponatremia with a sodium level of 128 mEq/L, potentially exacerbated by lithium therapy, which could contribute to his confusion and agitation. His blood alcohol concentration is undetectable, but a toxicology screen is positive for methamphetamine, indicating recent use that could potentiate his aggressive tendencies and complicate the management of his bipolar disorder. Additionally, his serum lithium level is on the lower end of the therapeutic range, suggesting suboptimal dosing that might be insufficient to stabilize his mood in the context of acute stressors.

These findings necessitate a reevaluation of the current treatment plan, focusing on addressing the acute physiological and psychiatric imbalances. The healthcare team must consider the delicate balance of managing his bipolar disorder, potential methamphetamine withdrawal, and lithium-induced hyponatremia, all while ensuring patient and staff safety. Close monitoring of cardiac function is imperative given his elevated blood pressure and heart rate, possibly necessitating the introduction of an antihypertensive agent. This multifaceted scenario requires precise coordination among the medical, psychiatric, and nursing teams to stabilize the patient and prevent further complications, setting the stage for the next phase of his complex care journey.

Section 2

As the healthcare team initiates interventions to address the patient's acute state, they implement a carefully titrated benzodiazepine regimen to mitigate his adrenergic hyperactivity and facilitate de-escalation. Concurrently, they adjust his lithium dosage to optimize mood stabilization while cautiously monitoring his serum sodium levels to avoid exacerbating the hyponatremia. Despite these efforts, the patient's condition evolves with the emergence of new complications that require immediate attention.

Within hours, the patient develops a fever of 38.7°C (101.7°F), and his heart rate climbs to 130 beats per minute, accompanied by a blood pressure reading of 180/95 mmHg. His respiratory rate increases to 28 breaths per minute, and he exhibits increased muscular rigidity, raising concerns for a neuroleptic malignant-like syndrome, possibly triggered by drug interactions or underlying metabolic disturbances. The team urgently reevaluates his medication regimen and initiates supportive measures to address these symptoms, including aggressive cooling strategies and hydration to manage his fever and prevent potential rhabdomyolysis.

In parallel, a repeat laboratory workup reveals a further drop in serum sodium to 125 mEq/L, necessitating the consideration of hypertonic saline administration to correct the hyponatremia while balancing the risks of central pontine myelinolysis. The complexity of his case intensifies as the team grapples with the interplay of his psychiatric condition, substance use, and now a suspected drug-induced hypermetabolic state. This multifaceted clinical picture demands heightened vigilance and collaborative decision-making to navigate the next phase of his treatment, with a focus on stabilizing his physiological parameters and re-assessing his psychiatric management plan.

Section 3

As the healthcare team continues to manage the patient's complex condition, they prioritize obtaining new diagnostic results to better understand the evolving complications. A comprehensive metabolic panel reveals that the patient's creatine kinase (CK) levels have skyrocketed to 15,000 U/L, confirming the suspicion of rhabdomyolysis. This imposes an urgent need for aggressive intravenous fluid therapy to prevent acute kidney injury, while maintaining careful monitoring to avoid exacerbating his hyponatremia. Concurrently, his liver function tests indicate an elevation in liver enzymes, with AST at 150 U/L and ALT at 180 U/L, suggesting possible hepatotoxicity that could be related to the medication adjustments or the hypermetabolic state.

Further assessment of the patient's neurologic status reveals a decreased level of consciousness, with a Glasgow Coma Scale score dropping to 10. The team conducts an urgent CT scan of the brain, which fortunately shows no acute intracranial abnormalities, but raises suspicion of potential metabolic encephalopathy or drug-induced sedation. These findings prompt a reevaluation of the patient's medication regimen, particularly the benzodiazepine and lithium dosages, to strike a balance between sedation and alertness. The team also consults with a neurologist to explore the possibility of an EEG to assess for subclinical seizure activity, given his fluctuating consciousness.

The complexity of the case is further compounded by the patient's laboratory tests indicating leukocytosis, with a white blood cell count of 18,000/mm³, raising the possibility of an infectious process or stress response. The team initiates broad-spectrum antibiotics as a precautionary measure while awaiting blood culture results. The patient's condition remains precarious, demanding continuous multidisciplinary collaboration to navigate these intersecting challenges and ensure that every intervention aligns with the overarching goal of stabilizing his physiological and psychiatric state.

Section 4

As the healthcare team continues to manage the patient's complex condition, a significant change in his status emerges overnight. The patient exhibits increased respiratory distress, with a respiratory rate climbing to 30 breaths per minute and oxygen saturation dropping to 88% on room air. Auscultation of the lungs reveals diffuse crackles, suggesting the development of pulmonary edema, potentially a result of aggressive fluid resuscitation for rhabdomyolysis. This respiratory compromise necessitates immediate intervention, including the initiation of supplemental oxygen therapy and consideration of diuretics to manage fluid overload, while cautiously balancing his electrolyte abnormalities.

Concurrently, the patient's neurological status continues to deteriorate, with the Glasgow Coma Scale score further declining to 8, indicating a worsening level of consciousness. The EEG performed by the neurologist reveals generalized slowing, consistent with metabolic encephalopathy, yet no definitive seizure activity is noted. This finding necessitates a reevaluation of the patient's metabolic state, focusing on correcting electrolyte imbalances and reviewing the potential hepatotoxic effects of his current medication regimen. The healthcare team decides to hold the next dose of lithium and adjust the benzodiazepine dosage to mitigate further CNS depression.

Amid these challenges, the blood culture results return positive for Gram-positive cocci, confirming the presence of a bacterial infection. This finding leads to the refinement of antibiotic therapy to target the specific pathogen identified, aiming to reduce the leukocytosis and systemic inflammatory response. The patient's precarious balance demands meticulous coordination among the multidisciplinary team, with continuous reassessment of his respiratory, neurologic, and metabolic parameters. The clinical reasoning process is further complicated by the need to anticipate and prevent potential complications such as acute respiratory failure or worsening hepatic function, setting the stage for the next critical phase of his care.

Section 5

In the midst of managing the patient's complex condition, a new complication arises: the patient's renal function shows signs of acute deterioration. Overnight laboratory results reveal a significant rise in creatinine to 3.2 mg/dL from a baseline of 1.1 mg/dL, indicating acute kidney injury likely secondary to both the aggressive fluid resuscitation and the nephrotoxic effects of the medications being administered. The patient's urine output has also decreased to less than 0.5 mL/kg/hr over the past six hours, further corroborating the concern for acute kidney injury. This necessitates a rapid reassessment of his fluid management strategy, balancing the need to resolve pulmonary edema with the imperative to preserve renal function.

Concurrently, the patient exhibits a new onset of atrial fibrillation with a rapid ventricular response, likely precipitated by electrolyte imbalances and increased cardiac workload due to fluid overload. His heart rate escalates to 140 beats per minute, and his blood pressure becomes labile, fluctuating between 90/60 mmHg and 140/80 mmHg. This arrhythmia adds another layer of complexity to his management, requiring careful titration of antiarrhythmic therapy while avoiding further compromise of his already impaired renal status. The decision to initiate a low-dose beta-blocker is considered, taking into account the patient's current hemodynamic instability and the potential impact on his respiratory status.

These developments demand a concerted effort from the multidisciplinary team to refine the patient's treatment plan. The nephrology team is consulted for input on renal replacement therapy options should his renal function continue to decline. Cardiologists are engaged to help stabilize the atrial fibrillation, and the primary team revisits the medication regimen to mitigate further nephrotoxic and hepatotoxic risks. The clinical reasoning process becomes increasingly intricate as the team works to optimize each aspect of care, ensuring that interventions in one domain do not inadvertently exacerbate issues in another. This careful orchestration of care aims to stabilize the patient and prevent further decompensation, setting the stage for the next critical steps in his journey.